Literature DB >> 22421492

On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.

D K Gordon1, R N Zadoks, H Stevenson, N D Sargison, P J Skuce.   

Abstract

The liver fluke, Fasciola hepatica, is a cause of significant economic losses in sheep farming. Lack of convenient and sensitive diagnostic tests in the live animal hampers the ability to monitor infection status and treatment efficacy. Use of a coproantigen ELISA and coproantigen reduction test, based on this ELISA, may address these issues but has, to date, only been evaluated in experimental challenge studies. We evaluated the coproantigen ELISA under working farm conditions in Scotland to assess its usefulness as a diagnostic test for liver fluke infection and as a diagnostic test to help determine the efficacy of flukicide treatment in sheep. First, liver fluke infection status was monitored longitudinally in a group of lambs, using monthly blood samples for biochemical assays and serum antibody ELISA and using monthly faecal samples for faecal egg count (FEC) and coproantigen ELISA. The average serum antibody ELISA titre became positive in September, two months ahead of faecal indicators of fluke infection. In contrast to results from experimental challenge studies, FEC and coproantigen ELISA became positive at the same time point. Secondly, treatment efficacy was measured in 100 ewes, from two farms, after treatment with triclabendazole (TCBZ) or closantel. Group level estimates of treatment efficacy were similar between faecal egg count reduction testing and coproantigen reduction testing at 7, 14 and 21 days post treatment. For individual animals, some inconsistencies between tests were observed. TCBZ treatment failure was noted on both farms, despite accurate weighing of animals and dosing of treatment products. We conclude that (1) coproantigen ELISA is a more convenient test than faecal egg counts and holds promise as a diagnostic tool for natural fluke infections in sheep but further evaluation of interpretation criteria may be needed; (2) the coproantigen ELISA has performed differently in the field compared with experimental challenge studies in sheep and (3) TCBZ-resistant fluke were present on both farms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22421492     DOI: 10.1016/j.vetpar.2012.02.009

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  14 in total

1.  Chicken IgY-based coproantigen capture ELISA for diagnosis of human opisthorchiasis.

Authors:  Salma Teimoori; Yuji Arimatsu; Thewarach Laha; Sasithorn Kaewkes; Piya Sereerak; Manop Sripa; Sirikachorn Tangkawattana; Paul J Brindley; Banchob Sripa
Journal:  Parasitol Int       Date:  2016-04-29       Impact factor: 2.230

2.  A Fascioliasis Case: a not Rare Cause of Hypereosinophilia in Developing Countries, Present in Developed too.

Authors:  Ismail Necati Hakyemez; Gülali Aktaş; Haluk Savli; Abdülkadir Küçükbayrak; Safiye Gürel; Tekin Taş
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-05-08       Impact factor: 2.576

3.  Rapid Enhanced MM3-COPRO ELISA for Detection of Fasciola Coproantigens.

Authors:  Victoria Martínez-Sernández; Ricardo A Orbegozo-Medina; Marta González-Warleta; Mercedes Mezo; Florencio M Ubeira
Journal:  PLoS Negl Trop Dis       Date:  2016-07-20

4.  Prevalence of Liver Fluke (Fasciola hepatica) in Wild Red Deer (Cervus elaphus): Coproantigen ELISA Is a Practicable Alternative to Faecal Egg Counting for Surveillance in Remote Populations.

Authors:  Andrew S French; Ruth N Zadoks; Philip J Skuce; Gillian Mitchell; Danielle K Gordon-Gibbs; Alexandra Craine; David Shaw; Stuart W Gibb; Mark A Taggart
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

5.  Combining Slaughterhouse Surveillance Data with Cattle Tracing Scheme and Environmental Data to Quantify Environmental Risk Factors for Liver Fluke in Cattle.

Authors:  Giles T Innocent; Lucy Gilbert; Edward O Jones; James E McLeod; George Gunn; Iain J McKendrick; Steve D Albon
Journal:  Front Vet Sci       Date:  2017-05-08

6.  First report of closantel treatment failure against Fasciola hepatica in cattle.

Authors:  Adam Novobilský; Johan Höglund
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-28       Impact factor: 4.077

7.  Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle.

Authors:  Yvette M Brockwell; Timothy P Elliott; Glenn R Anderson; Rex Stanton; Terry W Spithill; Nicholas C Sangster
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-12-11       Impact factor: 4.077

8.  Evaluation of the Performance of Five Diagnostic Tests for Fasciola hepatica Infection in Naturally Infected Cattle Using a Bayesian No Gold Standard Approach.

Authors:  Stella Mazeri; Neil Sargison; Robert F Kelly; Barend M deC Bronsvoort; Ian Handel
Journal:  PLoS One       Date:  2016-08-26       Impact factor: 3.240

9.  Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.

Authors:  Adam Novobilský; Natalia Amaya Solis; Moa Skarin; Johan Höglund
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-06-26       Impact factor: 4.077

10.  Constraints of using historical data for modelling the spatial distribution of helminth parasites in ruminants.

Authors:  Alizée Hendrickx; Cedric Marsboom; Laura Rinaldi; Hannah Rose Vineer; Maria Elena Morgoglione; Smaragda Sotiraki; Giuseppe Cringoli; Edwin Claerebout; Guy Hendrickx
Journal:  Parasite       Date:  2021-05-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.